ArticleStem cell research & therapy2024

Enhanced fetal hemoglobin production via dual-beneficial mutation editing of the HBG promoter in hematopoietic stem and progenitor cells for β-hemoglobinopathies.

Prathibha Babu Chandraprabha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.